KR920002330B1 - 주석 프로토포르피린 또는 주석 메조포르피린을 함유하는 건선 치료용 제약 조성물 - Google Patents

주석 프로토포르피린 또는 주석 메조포르피린을 함유하는 건선 치료용 제약 조성물 Download PDF

Info

Publication number
KR920002330B1
KR920002330B1 KR1019880700932A KR880700932A KR920002330B1 KR 920002330 B1 KR920002330 B1 KR 920002330B1 KR 1019880700932 A KR1019880700932 A KR 1019880700932A KR 880700932 A KR880700932 A KR 880700932A KR 920002330 B1 KR920002330 B1 KR 920002330B1
Authority
KR
South Korea
Prior art keywords
treatment
psoriasis
tin
week
patients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR1019880700932A
Other languages
English (en)
Korean (ko)
Other versions
KR890700026A (ko
Inventor
아탈라 카파스
죠지 에스. 드루몬드
레날트 암테스탐
Original Assignee
더 록펠러 유니버시티
윌리암 에이취. 그리사르
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 더 록펠러 유니버시티, 윌리암 에이취. 그리사르 filed Critical 더 록펠러 유니버시티
Publication of KR890700026A publication Critical patent/KR890700026A/ko
Application granted granted Critical
Publication of KR920002330B1 publication Critical patent/KR920002330B1/ko
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1019880700932A 1986-12-08 1987-12-07 주석 프로토포르피린 또는 주석 메조포르피린을 함유하는 건선 치료용 제약 조성물 Expired KR920002330B1 (ko)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US93882286A 1986-12-08 1986-12-08
US938,822 1986-12-08
US938822 1986-12-08
US07/125,011 US4782049A (en) 1986-12-08 1987-12-02 Tin protoporphyrin and tin mesoporphyrin in the treatment of psoriasis
US125,011 1987-12-02
US125011 1987-12-02
PCT/US1987/003248 WO1988004174A1 (en) 1986-12-08 1987-12-07 Use of tin protoporphyrin and tin mesoporphyrin in the treatment of psoriasis

Publications (2)

Publication Number Publication Date
KR890700026A KR890700026A (ko) 1989-03-02
KR920002330B1 true KR920002330B1 (ko) 1992-03-21

Family

ID=26823181

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880700932A Expired KR920002330B1 (ko) 1986-12-08 1987-12-07 주석 프로토포르피린 또는 주석 메조포르피린을 함유하는 건선 치료용 제약 조성물

Country Status (12)

Country Link
US (1) US4782049A (https=)
EP (1) EP0295280B1 (https=)
JP (1) JPH01501627A (https=)
KR (1) KR920002330B1 (https=)
AT (1) ATE63815T1 (https=)
AU (1) AU597144B2 (https=)
CA (1) CA1302253C (https=)
DE (1) DE3770465D1 (https=)
DK (1) DK443088D0 (https=)
IE (1) IE63507B1 (https=)
PH (1) PH25224A (https=)
WO (1) WO1988004174A1 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989002269A1 (en) * 1987-09-08 1989-03-23 The Rockefeller University Use of metalloporphyrins to reverse the toxic effect of tumor therapy
GR1000182B (el) * 1988-03-28 1992-01-20 Univ Rockefeller Χρησιμοποιηση πρωτοπορφυρινης κασσιτερου και μεσοπορφυρινης κασσιτερου στην παρασευη φαρμακευτικων συνθεσεων για την αγωγη της ψωριασης.
US4997828A (en) * 1989-02-14 1991-03-05 The Rockefeller University Method of weight control by low level administration of cobalt protoporphyrin or cobalt mesoporphyrin
US5192757A (en) * 1990-12-20 1993-03-09 Glaxo Inc. Cobalt porphyrins
US5149697A (en) * 1991-04-18 1992-09-22 Glaxo Inc. Cobalt porphyrin pharmaceutical compositions
TW247876B (en) 1993-12-28 1995-05-21 New York Blood Ct Inc Pharmaceutical compositions for prevention or treating HIV-1 or HIV-2 infection
AU1296795A (en) * 1993-12-28 1995-07-17 New York Blood Center, Inc., The Methods for preventing or treating hiv-1 or hiv-2 infection
AU2816195A (en) * 1994-06-02 1996-01-04 Bar-Ilan University Synergistic antibiotic compositions containing a perphyrin and an antibiotic
FR2727862B1 (fr) * 1994-12-07 1997-03-28 Holzmann Stephane Produits cosmetiques et/ou d'hygiene corporelle et/ou dermatologiques constitues d'une phase aqueuse isotonique et/ou d'une phase aqueuse osmotique
WO1997005152A1 (en) * 1995-08-02 1997-02-13 Warner-Lambert Company Amino acid complexes of cobalt (iii) mesoporphyrin ix and cobalt (iii) protoporphyrin ix
US7375216B2 (en) * 2002-06-04 2008-05-20 Infacare Pharmaceutical Corporation Preparation of metal mesoporphyrin compounds
AU2003237349B2 (en) 2002-06-04 2010-06-03 Infacare Pharmaceutical Corporation Preparation of metal mesoporphyrin halide compounds
US20040097481A1 (en) * 2002-11-20 2004-05-20 Benjamin Levinson Water-soluble mesoporphyrin compounds and methods of preparation
US20060222668A1 (en) * 2005-04-01 2006-10-05 Wellspring Pharmaceutical Corporation Stannsoporfin compositions, drug products and methods of manufacture
US7960371B2 (en) 2006-10-04 2011-06-14 Infacare Pharmaceutical Corporation High-purity large-scale preparation of stannsoporfin
PL2691398T3 (pl) 2011-03-30 2017-07-31 Infacare Pharmaceutical Corporation Sposoby syntezy mezoporfiryn metali
SI3200582T1 (sl) 2014-09-29 2024-04-30 Fred Hutchinson Cancer Center Sestave, kompleti in metode za indukcijo pridobljene citorezistence z uporabo induktorjev stresnih proteinov
CN117957005A (zh) * 2021-07-12 2024-04-30 雷尼布斯治疗公司 用于治疗bk病毒的金属原卟啉

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4454152A (en) * 1980-05-07 1984-06-12 Hoffmann-La Roche Inc. Methoxsalen dosage forms
US4657902A (en) * 1985-03-25 1987-04-14 The Rockefeller University Therapeutic use of tin mesoporphyrin
US4692439A (en) * 1986-06-20 1987-09-08 The Rockefeller University Therapeutic use of tin diiododeuteroporphyrin

Also Published As

Publication number Publication date
WO1988004174A1 (en) 1988-06-16
US4782049A (en) 1988-11-01
JPH0585523B2 (https=) 1993-12-07
AU597144B2 (en) 1990-05-24
CA1302253C (en) 1992-06-02
PH25224A (en) 1991-03-27
EP0295280A4 (en) 1989-02-21
ATE63815T1 (de) 1991-06-15
KR890700026A (ko) 1989-03-02
EP0295280B1 (en) 1991-05-29
DK443088A (da) 1988-08-08
IE63507B1 (en) 1995-05-03
EP0295280A1 (en) 1988-12-21
DE3770465D1 (de) 1991-07-04
IE873323L (en) 1988-06-08
DK443088D0 (da) 1988-08-08
JPH01501627A (ja) 1989-06-08
AU1081288A (en) 1988-06-30

Similar Documents

Publication Publication Date Title
KR920002330B1 (ko) 주석 프로토포르피린 또는 주석 메조포르피린을 함유하는 건선 치료용 제약 조성물
PARRISH et al. Comparison of PUVA and beta‐carotene in the treatment of polymorphous light eruption
Georgala et al. Topical use of minoxidil in children and systemic side effects
US6465514B1 (en) Methods and compositions for the promotion of hair growth
Boer et al. Comparison of phototherapy (UV-B) and photochemotherapy (PUVA) for clearing and maintenance therapy of psoriasis
Coleman et al. Palmoplantar psoriasis: experience with 8-methoxypsoralen soaks plus ultraviolet A with the use of a high-output metal halide device
US7442690B2 (en) Topical treatment for psoriasis
Mai et al. Childhood vitiligo successfully treated with bath PUVA
US5964224A (en) Method for treating amyotrophic lateral sclerosis and a therapeutic agent therefor
JPH06263644A (ja) リチウム治療剤
Belsito et al. The role of tar in Goeckerman therapy
Matsunami et al. Topical PUVA, etretinate, and combined PUVA and etretinate for palmoplantar pustulosis: comparison of therapeutic efficacy and the influences of tonsillar and dental focal infections
US5278172A (en) Method and composition for treating tendon or joint inflammation using a vasodilator
US5006510A (en) Method for relieving chronic pain with a somatostatin analog composition
Streit et al. Treatment of psoriasis with polyethylene sheet bath PUVA
LOWE Optimizing therapy: tazarotene in combination with phototherapy
Finlay Emollients as adjuvant therapy for psoriasis
Pearlman et al. Weekly psoriasis therapy using intralesional fluorouracil
US7705032B2 (en) Method and composition for treating burned skin
US20020009497A1 (en) Method of treatment for dermatological disorders and compositions therefor
Gomez et al. 8-MOP bath PUVA in the treatment of psoriasis: clinical results in 42 patients
Rampen Hypertrichosis in PUVA‐treated patients
JPH03170422A (ja) 皮膚疾患の治療法
JP2766811B2 (ja) 水性皮膚外用剤
Baldo et al. UVB phototherapy for pruritus in polycythaemia vera

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

FPAY Annual fee payment

Payment date: 19941123

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 19960322

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 19960322

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000